RTGN OTC
Apollo Beach, FL 33572
US
RetinalGenix Technologies Inc. is a company dedicated to research and development within the field of ophthalmology. Its core mission involves devising advanced technologies aimed at detecting, supervising, identifying, and treating a range of visual conditions, including those affecting the eyes and those that could lead to vision loss. Their product lineup features the RetinalGeniX Imaging System, an apparatus for broad-scale retinal imaging and screening that does not require pupil dilation, particularly useful for diabetic patients. Additionally, they offer the RetinalCam, a device designed for real-time retinal monitoring and imaging in a home setting, which includes an alert function for medical practitioners. The company was founded in 2017, with its principal offices located in Petaluma, California. RetinalGenix Technologies Inc. operates as a subsidiary of Sanovas Ophthalmology, LLC.
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Conley Richard K | A-Award | 5,000 | $3.35 | 2015-04-30 |
| Akao Akihisa | A-Award | 5,000 | $3.35 | 2015-04-30 |
| Oculus Innovative Sc | S-Sale | 350,000 | $2.75 | 2015-03-23 |
| Akao Akihisa | 0 | — | 2015-02-27 | |
| Conley Richard K | A-Award | 10,000 | $6.37 | 2014-05-12 |